Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Piper Sandler analysts initiated coverage on Jasper Therapeutics, Inc. (NASDAQ:JSPR) with a rating of Overweight on August 12, 2026.
Read moreBenchmark reiterated its Speculative Buy rating on Harvard Bioscience, Inc. (NASDAQ:HBIO) on August 12, 2026.
Read moreGuggenheim reiterated its Buy rating on Zura Bio Limited (NASDAQ:ZURA) on August 12, 2026.
Read moreWedbush reiterated its Outperform rating on Zura Bio Limited (NASDAQ:ZURA) on August 12, 2026.
Read moreCitizens reiterated its Market Outperform rating on Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) on August 12, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Velo3D, Inc. (NASDAQ:VELO) on August 12, 2026.
Read moreNeedham reiterated its Buy rating on Velo3D, Inc. (NASDAQ:VELO) on August 12, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Cartesian Growth Corporation III Unit (NASDAQ:CGCTU) on August 12, 2026.
Read moreDA Davidson reiterated its Buy rating on Black Rock Coffee Bar, Inc. Class A Common Stock (NASDAQ:BRCB) on August 12, 2026.
Read moreB. Riley Securities reiterated its Buy rating on DoubleDown Interactive Co., Ltd.
Read moreTruist Securities reiterated its Hold rating on Evolent Health, Inc. (NYSE:EVH) on August 12, 2026.
Read moreScotiabank reiterated its Sector Outperform rating on Lithium Argentina AG (NYSE:LAR) on August 12, 2026.
Read moreJP Morgan reiterated its Overweight rating on Eve Holding, Inc. (NYSE:EVEX) on August 12, 2026.
Read moreBMO Capital reiterated its Market Perform rating on Enviri Corporation (NYSE:NVRI) on August 12, 2026.
Read moreTruist Securities reiterated its Buy rating on Upstream Bio, Inc. (NASDAQ:UPB) on August 12, 2026.
Read moreUBS reiterated its Neutral rating on Ziff Davis, Inc. (NASDAQ:ZD) on August 12, 2026.
Read morePiper Sandler reiterated its Neutral rating on Leggett & Platt, Incorporated (NYSE:LEG) on August 12, 2026.
Read moreRoth Capital reiterated its Buy rating on Legence Corp. Class A Common stock (NASDAQ:LGN) on August 12, 2026.
Read moreLifeSci Capital analysts downgraded Liquidia Corporation (NASDAQ:LQDA) from Outperform to Market Perform on August 12, 2026.
Read moreNeedham reiterated its Buy rating on Liquidia Corporation (NASDAQ:LQDA) on August 12, 2026.
Read more
